Toxicity of octanoate and decanoate in rat peripheral tissues: evidence of bioenergetic dysfunction and oxidative damage induction in liver and skeletal muscle
- 21 October 2011
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 361 (1-2) , 329-335
Abstract
The accumulation of octanoic (OA) and decanoic (DA) acids in tissue is the common finding in medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD), the most frequent defect of fatty acid oxidation. Affected patients present hypoketotic hypoglycemia, rhabdomyolysis, hepatomegaly, seizures and lethargy, which may progress to coma and death. At present, the pathophysiological mechanisms underlying hepatic and skeletal muscle alterations in affected patients are poorly known. Therefore, in the present work, we investigated the in vitro effects of OA and DA, the accumulating metabolites in MCADD, on various bioenergetics and oxidative stress parameters. It was verified that OA and DA decreased complexes I–III, II–III and IV activities in liver and also inhibit complex IV activity in skeletal muscle. In addition, DA decreased complexes II–III activity in skeletal muscle. We also verified that OA and DA increased TBA-RS levels and carbonyl content in both tissues. Finally, DA, but not OA, significantly decreased GSH levels in rat skeletal muscle. Our present data show that the medium-chain fatty acids that accumulate in MCADD impair electron transfer through respiratory chain and elicit oxidative damage in rat liver and skeletal muscle. It may be therefore presumed that these mechanisms are involved in the pathophysiology of the hepatopathy and rhabdomyolysis presented by MCADD-affected patients.Keywords
This publication has 34 references indexed in Scilit:
- Newborn screening for disorders of fatty‐acid oxidation: experience and recommendations from an expert meetingJournal of Inherited Metabolic Disease, 2010
- Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brainNeurochemistry International, 2009
- Fatty Acid Oxidation DisordersAnnual Review of Physiology, 2002
- Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by d-2-hydroxyglutaric acid in vitroBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Fatty Acid Transport and Mitochondrial Oxidation DisordersSeminars in Liver Disease, 2001
- Succinate-cytochrome c reductase: assessment of its value in the investigation of defects of the respiratory chainBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Influence of fatty acids on energy metabolismEuropean Journal of Biochemistry, 1984
- Influence of fatty acids on energy metabolismEuropean Journal of Biochemistry, 1984
- SHORT COMMUNICATIONHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1980